Insulin degrading enzyme contributes to the pathology in a mixed model of Type 2 diabetes and Alzheimer’s disease: possible mechanisms of IDE in T2D and AD. The gene discussed is IDE; the disease is early-onset autosomal dominant Alzheimer disease.